Tivic Health Systems (TIVC) versus The Competition Critical

StockNews.com assumed coverage on shares of Zynerba Pharmaceuticals (NASDAQ:ZYNE – Get Rating) in a research note issued to investors on Thursday. The firm issued a sell rating on the stock. Separately, Cantor Fitzgerald reiterated an overweight rating on shares of Zynerba Pharmaceuticals in a research note on Friday, March 31st. One research analyst has rated […]

Related Keywords

, Zynerba Pharmaceuticals , Zynerba Pharmaceuticals Stock Down , Renaissance Technologies , Dimensional Fund Advisors , Cantor Fitzgerald , Hedge Funds Weigh In On Zynerba Pharmaceuticals , Millennium Management , Zynerba Pharmaceuticals Company Profile , News Ratings For Zynerba Pharmaceuticals Daily , Zynerba Pharmaceuticals Inc , Vanguard Group Inc , Get Rating , Pharmaceuticals Stock Down , Sigma Investments , Fund Advisors , Zynerba Pharmaceuticals Daily , Nasdaq Zyne , Zyne , Medical , Initiated Coverage , Stocknews Com ,